Literature DB >> 17651920

Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits.

Eusebio Lavara-Culebras1, Nuria Paricio.   

Abstract

Parkinson's disease (PD) is a progressive movement disorder caused by the selective and massive loss of dopaminergic neurons (DA) in the substantia nigra pars compacta (SNc). DJ-1 loss-of-function mutations are involved in inherited early-onset PD forms and result in dysfunction of the oxidative stress response. In mice models, DJ-1 loss provokes sensitivity to oxidative insults but does not produce neurodegeneration. Similar results have been found when analyzing Drosophila mutants for the DJ-1 orthologous genes, DJ-1alpha and DJ-1beta. Here, we report the analysis of two new mutations for the Drosophila DJ-1 genes. Both ubiquitous induction of DJ-1alpha knockdown by RNAi and loss of function of DJ-1beta caused by an insertional mutation result in increased sensitivity to paraquat insults, reduced lifespan and motor impairments. However these mutations do not lead to DA neuron loss. Besides, we find that targeted inhibition of DJ-1alpha function in DA neuron results in certain DA neurodegeneration. Our results, together with findings in other Drosophila DJ-1 mutants, indicate that both Drosophila DJ-1 genes are implicated in the protection against the chemical induced oxidative stress response, but also in fly survival. The differences observed in DA neurodegeneration suggest that the motor impairments exhibited by the mutants could be caused by different pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651920     DOI: 10.1016/j.gene.2007.06.013

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  33 in total

Review 1.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis.

Authors:  Rebecca Banerjee; Anatoly A Starkov; M Flint Beal; Bobby Thomas
Journal:  Biochim Biophys Acta       Date:  2008-11-14

2.  Structural effects of Parkinson's disease linked DJ-1 mutations.

Authors:  Gaetano Malgieri; David Eliezer
Journal:  Protein Sci       Date:  2008-05       Impact factor: 6.725

3.  Parkinson disease-associated DJ-1 is required for the expression of the glial cell line-derived neurotrophic factor receptor RET in human neuroblastoma cells.

Authors:  Rossana Foti; Silvia Zucchelli; Marta Biagioli; Paola Roncaglia; Sandra Vilotti; Raffaella Calligaris; Helena Krmac; Javier Enrique Girardini; Giannino Del Sal; Stefano Gustincich
Journal:  J Biol Chem       Date:  2010-04-15       Impact factor: 5.157

Review 4.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

Review 5.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

6.  The E163K DJ-1 mutant shows specific antioxidant deficiency.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

Review 7.  Update on the pathogenesis of Parkinson's disease.

Authors:  Jörg B Schulz
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

8.  The Parkinson's disease gene DJ-1 is also a key regulator of stroke-induced damage.

Authors:  Hossein Aleyasin; Maxime W C Rousseaux; Maryam Phillips; Raymond H Kim; Ross J Bland; Steve Callaghan; Ruth S Slack; Matthew J During; Tak W Mak; David S Park
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

9.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

10.  Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains.

Authors:  Stéphanie Baulac; Hope Lu; Jennifer Strahle; Ting Yang; Matthew S Goldberg; Jie Shen; Michael G Schlossmacher; Cynthia A Lemere; Qun Lu; Weiming Xia
Journal:  Mol Neurodegener       Date:  2009-02-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.